Review
Open access
Aug 2026
An evaluation of the use of the Universal Benefit-Risk Assessment Framework by the Zambia Medicines Regulatory Authority for documenting and communicating benefit-risk decisions.
This study evaluated the feasibility, usability and perceived value of applying UMBRA within the Zambia Medicines Regulatory Authority (ZAMRA) and compared the explicitness and structure of UMBRA benefit-risk documentation with the existing narrative approach.
Constance Sakala Chisha, Stephanie Leigh, Prudence Musonda Mubanga et al.
· Regulatory toxicology and ph... · 0 citations